The diet, which is rich in fats and low in carbohydrates, may help alter how your body manages and utilises energy, ...

The diet, which is rich in fats and low in carbohydrates, may help alter how your body manages and utilises energy, ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

The nonclinical pharmacokinetic (PK) and pharmacodynamic (PD) study was conducted to examine the effects of semaglutide ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Gut bacteria-produced exopolysaccharides (EPS) help regulate metabolism by modulating gut microbiota, promoting SCFA ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.